The Ataxia Community Comes Together in Orlando April 9–11, 2026 for the Annual Ataxia Conference! LEARN MORE
All About Troriluzole
December 10, 2024 @ 1:00 pm - 2:00 pm
CENTRAL TIME ZONE
We have received lots of questions from our community about Troriluzole, an investigational therapy for SCA. In this session, we will go over some of the most common questions we have received about Troriluzole. Then there will be an open Q&A session for attendees to ask their own questions.
Troriluzole is an investigational therapy that is under evaluation and not approved by the FDA. Anyone considering participating in a clinical trial or trying a new medication should discuss the matter with their physician. The National Ataxia Foundation does not endorse or recommend particular studies or treatment options
Register: Click here.
Other Webinars
NAF hosts educational webinars about Ataxia presented by industry experts. Learn about important topics related to living with Ataxia. Webinars are complimentary for NAF members, with new sessions offered each month. Join NAF to receive invitations to upcoming Ataxia webinars. Visit www.ataxia.org/webinars to explore past webinars on a variety of topics.
